Ghrelin Levels in Pancreatic Cancer Patients

Completed

Conditions studied: Pancreatic Cancer

In brief

The primary outcome measure for this study is plasma ghrelin level.

Key facts

Study ID

NCT00225745

Run by

Dartmouth-Hitchcock Medical Center

People needed

72

Starts

2004-04-01

Expected to finish

2015-09-01

Last updated by the study team

2015-10-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Histological or cytological proof of pancreatic adenocarcinoma
• The control are will include healthy age-matched patients without cancer
• The test arm will include patients with pancreatic cancer and they will divided into two groups: those with and without weight loss
• Patients must have recovered from any major infections and/or surgical procedures

You may not qualify if…

• Patients with other serious medical illness like congestive heart failure, thyroid disease,liver disease or renal failure - conditions that will alter their nutritional state
• Patients on appetite stimulant and those receiving total parenteral nutrition
• Patients who have undergone gastrectomy or those who have gastric ulcers
• Patients receiving active chemotherapy
• No prior malignancy except for adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer or for which patient has been disease free for at least five years.

Where it is running

• Dartmouth Hitchcock Medical Center/Norris Cotton Cancer Center — Lebanon, New Hampshire, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.